
S. George Barreto
@sgeorgebarreto
GI, HPB & Liver Transplant Surgeon👨🏻⚕️ Researcher🔬 Teacher 📚 Dy. Director (Flinders MD) 🇦🇺 #heforshe Member @WorldJSurg 💪🏽 Soccer Enthusiast ⚽️🕎
ID: 1489582843411898372
https://www.flinders.edu.au/people/savio.barreto 04-02-2022 12:53:42
1,1K Tweet
838 Takipçi
319 Takip Edilen



Disappoints me that we keep publishing these types of articles. I worry people who don’t understand stats, selection, or biology will take this as a green light to operate. M1 dz is a contraindication to operate for PDAC. Full stop. SURGERY Journal surgjournal.com/article/S0039-…

Honored to co-author this review with the exceptional Eileen M O’Reilly, a true leader, mentor, and inspiration. Thank you for your guidance on "Precision Oncology in Pancreatic Cancer and Future Treatment Directions" - full text here: surgonc.theclinics.com/article/S1055-…

Review: The Hallmarks of Cancer as Eco-Evolutionary Processes brnw.ch/21wSaye By Ranjini Bhattacharya, Stanislav S. Avdieiev, Anuraag Bukkuri, Christopher J. Whelan, Robert A. The Gatenby Lab, Kenneth Y. Tsai, and Joel S. Brown. Moffitt Research UPMC Hillman Cancer Center @thisisuic










A Nature Medicine paper from Geneseeq (China), which has developed a fragmentomics based MCED assay (CANSCAN): Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics nature.com/articles/s4159… Figure below on prospective asymptomatic cohort:



Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study British Journal of Cancer nature.com/articles/s4141…



